Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus.
Matassov D, DeWald LE, Hamm S, Nowak RM, Gerardi CS, Latham TE, Xu R, Luckay A, Chen T, Tremblay M, Shearer J, Wynn M, Eldridge JH, Warfield K, Spurgers K.
Matassov D, et al. Among authors: wynn m.
Vaccines (Basel). 2024 Jul 30;12(8):858. doi: 10.3390/vaccines12080858.
Vaccines (Basel). 2024.
PMID: 39203984
Free PMC article.